Hematoxylin and Eosin staining of the additional tissues explanted at euthanasia exhibited no adverse effects from VEGF administration at distal sites, e.g., oedema, hemangiomas (Figure S3, Supporting Information). This evidence concerns the gene VEGFA and hemangioma.